Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The most commonly reported injection site symptoms include: Erythema and warmth transient redness and increased temperature at the injection location Pruritus localized itching that generally resolves within hours to days Induration firm swelling or hardness of subcutaneous tissue Bruising ecchymosis from capillary disruption during injection Pain or tenderness mild discomfort that typically diminishes rapidly While generalized skin sensitivity is not among the most common adverse effects, the FDA labels for both Mounjaro and Zepbound include warnings about the potential for serious hypersensitivity reactions, including anaphylaxis and angioedema, though these are rare
While multiple market factors are at play, many analysts believe that the mainstreaming of GLP-1 drugsappetite suppressants by designis playing an increasingly important role
Who can get it: Ozempic and Rybelsus require a diagnosis of type 2 diabetes (although Ozempic can be prescribed off-label for weight loss), while Wegovy requires either a BMI of 30 or a BMI of at least 27 plus another weight-related ailment (like high blood pressure or obstructive sleep apnea)
As of April 4, President Trump had rejected Bidens proposal to expand GLP-1 coverage for obesity to Medicare and Medicaid
Tirzepatide for Cardiovascular Health Both retatrutide and tirzepatide are currently in phase 3 trials for their potential in reducing the risk of cardiovascular problems in patients with T2D or obesity
